Skip to main content

Table 2 Change in risk marker values from baseline to 3-months

From: Effects of omega-3 fatty acids on arterial stiffness in patients with hypertension: a randomized pilot study

  Placebo (N = 35)
Mean (SD)
Omega-3 (N = 27)
Mean (SD)
Pulse Wave Velocity (cm/s) −33 (306) −97 (182)
Total cholesterol (mg/dL) −6.6 (30.4) −0.8 (18.1)
Triglycerides (mg/dL) −30.0 (58.1) −17.6 (45.6)
HDL-C (mg/dL) 0.2 (8.5) 2.9 (14.6)
LDL-C (mg/dL) −2.8 (28.6) 0.7 (18.3)
Hemoglobin A1c (%) −0.13 (0.94) 0.06 (0.44)
Glucose (mg/dL) −13.1 (44.0) 0.6 (23.0)
hsCRP (mg/L) 0.9 (4.4) −0.9 (3.1)
Adiponectin (ug/mL) 0.3 (3.4) −0.4 (2.4)
LpPLA2 mass (ng/mL) −6.1 (31.7) −18.1 (41.1)
  1. CRP C-reactive protein, Lp-PLA2 lipoprotein-associated phospholipase A2
\